A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/145 (2006.01) A61P 1/16 (2006.01)
Patent
CA 2706768
The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non- alcoholic steatohepatitis (NASH).
La présente invention concerne, de façon générale, le traitement de troubles associés à une stéatose hépatique, comprenant l'administration de compositions comportant des produits à base de cystéamine. L'invention concerne également l'administration de compositions à base de cystéamine à enrobage entérique en vue du traitement de troubles associés à une stéatose hépatique, comme la stéatose hépatique non alcoolique et la stéatohépatite non alcoolique.
Dohil Ranjan
Schneider Jerry
Smart & Biggar
The Regents Of The University Of California
LandOfFree
Methods of treating non-alcoholic steatohepatitis (nash)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating non-alcoholic steatohepatitis (nash)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating non-alcoholic steatohepatitis (nash)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1710216